News Headlines

  1. Pfizer And BioNTech Announce An Agreement With U.S. Government For Up To 600 Million Doses Of mRNA-Based Vaccine Candidate Against SARS-CoV-2 7/22/2020

    Pfizer Inc. and BioNTech SE today announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of Defense to meet the U.S. government’s Operation Warp Speed program goal to begin delivering 300 million doses of a vaccine for COVID-19 in 2021.

  2. CMIC Group Establishes A New Biologic Contract Development And Manufacturing Business In Japan 7/22/2020

    CMIC HOLDINGS Co., Ltd.（Head Office: Tokyo, Minato-ku, Representative Director & CEO Kazuo Nakamura, hereafter “CMIC”）announced today the establishment of CMIC BIO Co., Ltd. (hereafter CMIC BIO), a fully-owned subsidiary that offers Contract Development and Manufacturing Organization (hereinafter CDMO) services for biopharmaceutical drug substance.

  3. Gilead Sciences Secures Exclusive Option To Acquire Tizona Therapeutics For $300M 7/21/2020

    Gilead Sciences, Inc. today announced that it will invest $300M to acquire a 49.9 percent equity interest in Tizona Therapeutics, Inc., a privately held company developing first-in-class cancer immunotherapies.

  4. Catalent Biologics To Invest $30M To Create European Clinical Manufacturing Center Of Excellence In Limoges, France 7/21/2020

    Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it plans to invest $30M (€27M) at its facility in Limoges, France, to create a European center of excellence for clinical biologics formulation development and drug product fill-finish services.

  5. SCA Pharma To Expand Production Facility In Little Rock 7/21/2020

    SCA Pharma, an FDA-registered outsourcing facility, today announced that it will expand its operations in Little Rock. SCA will be investing more than $10M and will create the opportunity to double its current Little Rock workforce of 180 people.

  6. Grifols To Acquire Green Cross Plasma Fractionation Facility In Montreal And A Plasma Collection Organization In The U.S. For US$460M 7/20/2020

    Grifols, a global healthcare company and one of world’s top producers of plasma-derived medicines, today announced it has executed purchase arrangements with the South Korean-based GC Pharma (Group) whereby Grifols will acquire the Montreal-based plasma fractionation facility and two purification facilities, along with 11 U.S.-based plasma collection centers for a total amount of US$460M.

  7. IRISYS, A San Diego CDMO, To Manufacture BioCorRx’s Opioid Use Disorder Treatment Implant 7/20/2020

    IRISYS LLC, a pharmaceutical contract development and manufacturing company (CDMO), provides contract development and GMP manufacturing services to BioCorRx Pharmaceuticals, Inc., related to a sterile naltrexone sub-cutaneous implant, also known as BICX102, which is meant to help in the treatment of OUD and the prevention of relapse following opioid detoxification.

  8. GSK And CureVac Announce Strategic mRNA Technology Collaboration 7/20/2020

    GlaxoSmithKline plc and CureVac today announced the signing of a strategic collaboration agreement for the research, development, manufacturing and commercialisation of up to five mRNA-based vaccines and monoclonal antibodies (mAbs) targeting infectious disease pathogens. The collaboration complements GSK’s existing mRNA capabilities with CureVac’s integrated mRNA platform.

  9. MilliporeSigma Invests $20M In New Switzerland Laboratory 7/15/2020

    MilliporeSigma has announced plans to build a new, $20M laboratory facility in Buchs, Switzerland to support its rapidly growing reference materials business.

  10. Quartic.ai Announces Partnership With Sparta Systems To Connect Real-Time Manufacturing Insights To QMS 7/14/2020

    Quartic.ai, provider of the award-winning Quartic AI and IoT Platform for Smart Industry, announced a partnership with Sparta Systems, Inc., provider of industry-leading Quality Management System (QMS) platforms TrackWise and TrackWise Digital, to bring forward next-level AI capabilities for early risk detection during the manufacturing process to reduce product quality impact and enable near-real-time product release.